Cantor Starts CRISPR Therapeutics (CRSP) at Overweight, 'A Year of Catalysts Could Bring Money Back into This Gene Editing Play'
Go back to Cantor Starts CRISPR Therapeutics (CRSP) at Overweight, 'A Year of Catalysts Could Bring Money Back into This Gene Editing Play'| (NASDAQ: CRSP) | Delayed: 53.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.99 | 52 Week High | $18.88 | |||
| Open | $53.99 | 52 Week Low | $13.75 | |||
| Day High | $53.99 | P/E | N/A | |||
| Day Low | $53.99 | EPS | $0.00 | |||
| Volume | 914 | |||||
